Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion type Assertion NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_head.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion description "[A case for LANCL2-based drug discovery and development is also illustrated by the anti-inflammatory activity of novel LANCL2 ligands such as NSC61610 against inflammatory bowel disease and influenza-driven inflammation in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_provenance.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion evidence source_evidence_literature NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_provenance.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion SIO_000772 24628287 NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_provenance.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion wasDerivedFrom befree-20150227 NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_provenance.
- NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_assertion wasGeneratedBy ECO_0000203 NP922046.RAZ9VitxoC2UAaWrA80-sCVm0dyYzK-3SLkb_SEfg6Ci0130_provenance.